Re Cyte Therapeutics Corp is categorized under Medical Centers in Alameda, CA and active since 2011.
Re Cyte Therapeutics Corp was established in 2011, and today employs 1 to 4, earning Unknown per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number 5417110 by the NAICS.
If you are seeking more information, feel free to contact Michael West, Chief Executive Officer at the company’s single location by writing to 1301 Harbor Bay Parkway # 100, Alameda, California CA 94502 or by phoning (510) 521-3390. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Re Cyte Therapeutics Corp |
| Contact Person: | Michael West, Chief Executive Officer |
| Address: | 1301 Harbor Bay Parkway # 100, Alameda, California 94502 |
| Phone Number: | (510) 521-3390 |
| Website Address: | recytecorp.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Centers |
| SIC Code: | 8011 |
| NAICS Code: | 5417110 |
| Share This Business: |
Re Cyte Therapeutics Corp was started in 2011 to provide professional Medical Centers under the SIC code 8011 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Michael West, Chief Executive Officer for inquiries that concern Re Cyte Therapeutics Corp by calling the company number (510) 521-3390, as your correspondence is most welcome. Additionally, the physical location of the single location of Re Cyte Therapeutics Corp can be found at the coordinates 37.72593,-122.23431 as well as the street address 1301 Harbor Bay Parkway # 100 in Alameda, California 94502.
For its online presence, you may visit Re Cyte Therapeutics Corp’s website at recytecorp.com and engage with its social media outlets through on Twitter and on Facebook.